Jobs With Higher COPD Risk Prompt Need for Preventive Strategies
Several occupational categories increased the risk for chronic obstructive pulmonary disease in nonsmoking/nonasthmatic individuals.
Chronic Obstructive Pulmonary Disease
Bronchodilator Reversibility May Not Distinguish Asthma From COPD
Measures of reversibility are of limited value for distinguishing smoke-related chronic obstructive pulmonary disease from asthma, but bronchodilator response testing may be a phenotypic marker for asthma.
Visual Scoring of Emphysema May Predict Risk for Lung Cancer
Visual scoring of emphysema is predictive of an individual’s risk for lung cancer, with the centrilobular emphysema phenotype associated with the greatest risk.
Classification of COPD Severity With Visual and Quantitative CT Features
Researchers have proposed a potentially useful way to categorize chronic obstructive pulmonary disease at diagnosis based on the classification of specific subtypes, according to a combination of visual and quantitative CT parameters.
GOLD Board of Directors Calls for More Serious Action on COPD
The board of directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recently published an editorial urging more serious action should be taken to better manage chronic obstructive pulmonary disease.
Prevalence of Osteoporosis in COPD Prompts Need for Screening
Significant risk factors for osteoporosis among patients with COPD included low body mass index and the presence of sarcopenia.
Risk for Lower Back Pain Seen With Asthma, COPD
Patients with asthma and/or chronic obstructive pulmonary disease have an increased risk for the development of long-term lower back pain.
COPD-Related Cognitive Impairment Unlike Other Forms of Dementia
The prevalence of cognitive impairment is higher in patients with COPD compared with healthy individuals.
Air Pollution Found to Accelerate Aging of the Lungs
Higher exposures to each pollutant were significantly associated with lower lung function.
Glycopyrronium Bromide Delivered by Dry Powder Inhaler vs eFlow Nebulizer in COPD
In patients with chronic obstructive pulmonary disease, glycopyrronium bromide delivered by a dry powder inhaler may be associated with steadier state levels of drug compared with a novel closed system vibrating membrane nebulizer.
Next post in COPD
